Meet the AIEOP’s 2024-2027 Board Of Directors: President, Angela Mastronuzzi
AIEOP: Italian Association of Pediatric Hematology and Oncology shared a post on LinkedIn:
“Meet The 2024-2027 Board Of Directors.
Please welcome the President of AIEOP: Angela Mastronuzzi, MD, PhD, Head of the Neuro-Oncology Unit at Bambino Gesù Children’s Hospital.
Holds an MD with a specialization in Pediatrics from the Catholic University of the Sacred Heart, a PhD in Molecular Science from Sapienza University of Rome and master’s degree in Child Neurology from University of Rome Tor Vergata.
Contract Professor, lecturing within several masters and PhD programs.
A pediatric hematologist-oncologist with specific focus on central nervous system tumors and cancer predisposing syndromes.
Extensive knowledge in innovative and personalized treatments with a multidisciplinary approach for pediatric cancer, notably in phase I clinical trials, targeted therapy, cell therapy and gene therapy.
Serves Principal Investigator and Sub-Investigator for over 50 phase I/II/III trials and protocols and clinical research includes over 215 publications.
Active member and designated reference for OPBG within the ERN Genturis and ERN PaedCan networks.
EU funded projects focusing on AI in pediatric cancer, including EU4CHILD, UNICA4EU, ACCELERATE Multi-Stakeholder Platform, and EDHEN.
Part of multiple AIEOP working groups and specifically within OPBG she is Head of the Neuro-Oncology Working Group.
Internationally, she is part of brain tumor working groups such as SIOP-Europe and ITCC Consortium.
Serves as a board member for the Virtual Institute of Neuro-Oncology, part of the Italian Neuroscience network, INCiPiT – Italian Network for Paediatric Clinical Trials and Tender to Nave Italia ETS Foundation.”
More posts featuring AIEOP.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023